Építés alatt – nem éles oldal
Belépés

What researchers published on Pompe-betegség

1192 papers, newest first.

Showing 40 of 1192

  • Patient perspectives of participation in clinical studies in late-onset Pompe disease: Structured exit interviews from cipaglucosidase alfa plus miglustat studies.Therapeutic advances in rare disease
  • High-Risk Screening for Late-Onset Pompe Disease in Northern China: Prevalence, Genotypic Spectrum, and Diagnostic Challenges.JIMD reports
  • High-Fat, High-Protein, Carbohydrate-Restricted Dietary Interventions in Pompe Disease: A Case Series with Long-Term Follow-Up.Annals of nutrition & metabolism
  • A novel technology-driven enzyme replacement therapy for Pompe disease.Molecular therapy. Advances
  • ÁttekintésInfusion-associated reactions during enzyme replacement therapy in late-onset Pompe disease: a systematic review and proposed management algorithm.Molecular genetics and metabolism
  • EsetismertetésRecurrent Reactions to Enzyme Replacement Therapy in Infantile-Onset Pompe Disease: A Case of Immunologic Barriers to Drug Tolerance.American journal of medical genetics. Part A
  • EsetismertetésEarly Cardiac Involvement in Late-Onset Pompe Disease: A Case Report from an Iranian Consanguineous Family.Iranian journal of child neurology
  • Szisztematikus áttekintésThe Genetic Landscape of Pompe Disease in the Middle East, North Africa, and Turkey (MENAT Region): A Systematic Review of GAA Variants and Genotype-Phenotype Correlation.International journal of molecular sciences
  • Home-Based Versus Hospital-Based Administration of Enzyme Replacement Therapy for Late-Onset Pompe Disease in Greece: A Cost-Utility and Budget Impact Analysis.Applied health economics and health policy
  • Efficacy and safety of cipaglucosidase alfa plus miglustat in Japanese adults with late-onset Pompe disease: a case series from clinical trials.BMJ neurology open
  • ÁttekintésInfantile-Onset Pompe Disease: Current Therapeutic Landscape, Clinical Challenges, and Future Horizons.Cureus
  • Of Pompe and Circumstance: A Case Review of Late Onset Pompe Disease in a 52-Year-Old Male.Case reports in rheumatology
  • Evaluation of Pompe Disease from a Broad and Systemic Perspective.Journal of clinical practice and research
  • Identifying regulatory muscle processes in infantile and adult Pompe patients using a multi-omic and morphological approach.Brain pathology (Zurich, Switzerland)
  • Generation and characterization of a human iPSC line (XACHi022-A) derived from an asymptomatic carrier of the GAA c.2051C > A (p.P684Q) variant.Stem cell research
  • Two novel GAA missense variants and a known VUS in pompe disease: Functional characterization and pharmacological chaperone therapy.Genes & diseases
  • A High-Fat, High-Protein, Carbohydrate-Restricted Dietary Interventions in Pompe Disease: A Case Series with Long-Term Follow-Up.Annals of nutrition & metabolism
  • Nocturnal sleep abnormalities occur before motor function deterioration in early-treated patients with infantile-onset Pompe disease: a two-decade newborn screening cohort study.Neuromuscular disorders : NMD
  • Enzyme replacement therapy (ERT) combined with transient low-dose methotrexate (TLD-MTX) results in age- and disease-dependent immune profile changes in Infantile- vs. late-onset Pompe disease patients.Frontiers in immunology
  • EsetismertetésLate-Onset Pompe Disease.The New England journal of medicine
  • Megfigyeléses vizsgálatScreening for potential late-onset Pompe disease patients among individuals with suspected sleep apnea: A prospective, multicenter observational Cohort Study in Japan (PSSAP-J Study).Sleep & breathing = Schlaf & Atmung
  • Corrigendum to "Early detection in action: developing and refining newborn screening for Pompe disease in North Carolina" [Mol. Genet. Med. 149 (1-2) (2026) 110252].Molecular genetics and metabolism
  • Preliminary clinical application of two-dimensional speckle tracking echocardiography in adult-onset glycogen storage disease type II.Archives of physiology and biochemistry
  • The Effect of Anti-drug Antibodies on the Bioavailability of Alglucosidase Alfa in Classic Infantile Pompe Disease.BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
  • ÁttekintésGenome Editing for Glycogen Storage Diseases.Journal of inherited metabolic disease
  • Epilepsy Is Part of the CNS Phenotype in Classic Infantile Pompe Disease.Neurology. Genetics
  • Early detection in action: developing and refining newborn screening for Pompe disease in North Carolina.Molecular genetics and metabolism
  • Functional characterization of 42 GAA missense variants using a validated in vitro cellular functional assay.Molecular genetics and metabolism
  • Nociceptive pain in late-onset Pompe disease: prevalence, distribution, and clinical correlates.Journal of neurology
  • GAA engineered to improve cellular uptake enhances correction in a preclinical hematopoietic stem cell gene therapy model of Pompe disease.Molecular therapy. Advances
  • A Protocol for Multidisciplinary Rehabilitation Combined with Enzyme Replacement Therapy for Ventilator Weaning in Late-Onset Pompe Disease.Journal of visualized experiments : JoVE
  • Pompe Disease: From a Cardiovascular Lens.Cardiology in review
  • Megfigyeléses vizsgálatExpiratory phase lung mechanics in late-onset Pompe disease: a multicenter study using oscillometry to identify specific breathing abnormalities.Orphanet journal of rare diseases
  • AAV9-mediated GAA gene therapy following enzyme replacement therapy discontinuation in children with infantile-onset Pompe disease.EClinicalMedicine
  • Disease duration and phenotypic heterogeneity in late-onset Pompe disease: Implications for individualized therapy.Molecular genetics and metabolism
  • ÁttekintésDefining the therapeutic corridor of stability in enzyme replacement therapy for Pompe disease: a position statement.Orphanet journal of rare diseases
  • Szisztematikus áttekintésCentral nervous system histopathological findings in classic infantile Pompe disease: a systematic review with clinical relevance.Journal of neurology
  • Home Infusion With Recombinant Human α-Glucosidase in Children With Pompe Disease: The Dutch Experience Over 20 Years Across the Spectrum From Classic Infantile to Late-Onset Phenotypes.BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
  • Real-Life Effectiveness After Switching to Avalglucosidase Alfa in Late-Onset Pompe Disease Patients Worsening on Alglucosidase Alfa Therapy: A French Cohort Study.European journal of neurology
  • A disease progression model comparing the long-term mobility and respiratory outcomes of adults with late-onset Pompe disease receiving cipaglucosidase alfa plus miglustat versus alglucosidase alfa.Journal of comparative effectiveness research